EPISODE · Oct 29, 2025 · 31 MIN
Biologic Tapering in axSpA: What Research Says and What it Means for Patients
from Spondycast
Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.
NOW PLAYING
Biologic Tapering in axSpA: What Research Says and What it Means for Patients
0:00
31:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Spondycast?
This episode is 31 minutes long.
When was this Spondycast episode published?
This episode was published on October 29, 2025.
What is this episode about?
Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.
Can I download this Spondycast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!